---
title: "Simpson Interventions announces US FDA regulatory milestones"
date: "2025-01-07T16:46:08.000Z"
publishedDate: "7 janvier 2025"
summary: "Simpson Interventions has announced that the Acolyte image-guided crossing and re-entry catheter system has been granted an investigational device exemption (IDE) by the US Food and Drug Administration (FDA), after having been designated as a breakthrough device last year. Additionally, the company also announced that its Shadow catheter has received 510(k) clearance from the FDA."
importance: ""
sourceUrl: "https://cardiovascularnews.com/simpson-interventions-announces-fda-regulatory-milestones/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-01-07-simpson-interventions-announces-us-fda-regulatory-milestones"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/07/cath-lab-generic.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/simpson-interventions-announces-fda-regulatory-milestones/"
---

![Simpson Interventions announces US FDA regulatory milestones](https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/07/cath-lab-generic.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/simpson-interventions-announces-fda-regulatory-milestones/*

## L’essentiel

Simpson Interventions has announced that the Acolyte image-guided crossing and re-entry catheter system has been granted an investigational device exemption (IDE) by the US Food and Drug Administration (FDA), after having been designated as a breakthrough device last year. Additionally, the company also announced that its Shadow catheter has received 510(k) clearance from the FDA.

## Lien source

https://cardiovascularnews.com/simpson-interventions-announces-fda-regulatory-milestones/
